Know a great AI tool or AI news source? Submit it to AiByts
Updated

Epilogue. Write novels, scripts & poetry

Writing studio with flow, feedback, and publishing tools

    Epilogue. Write novels, scripts & poetry news & updates

    • Download epilogue

      All your files are plain .md files you own. If you ever want to leave, you just... leave. No lock-in.

      Epilogue. Write novels, scripts & poetry Blog1 min read
    • Privacy Policy

      Last Updated: 2024.04.02 At Epilogue, your privacy and the protection of your data is our top priority. Epilogue is built on a local-first architecture — your writing lives on your device first, not on our servers.

      Epilogue. Write novels, scripts & poetry Blog5 min read
    • Delete My Data

      Last Updated: 2024.04.02 Epilogue does not collect your name or email address, so we have no way to identify you from the outside. Deletion must be initiated from within the app, where your sync key lives.

      Epilogue. Write novels, scripts & poetry Blog1 min read
    • Epilogue

      Changelog All notable changes to Epilogue are documented here. [v 1.1.3+13] — 2026-05-07 Added Drag-and-drop chapter reordering: You can now grab any heading in the outline sidebar and drag it up or down to reorder entire chapters.

      Epilogue. Write novels, scripts & poetry Blog4 min read
    • Support

      We’re here to help Epilogue offers world-class email support. Whether you have a question, run into a problem, or just want to share feedback. You can reach the founder directly, anytime. Email: rav@epilogue.page No support tickets routed through a bot. No waiting on a faceless team.

      Epilogue. Write novels, scripts & poetry Blog1 min read

    Details are compiled from Epilogue. Write novels, scripts & poetry's website and public sources, last verified Oct 5, 2026. Features and pricing change — confirm on the official site before you buy.

    Try Epilogue. Write novels, scripts & poetry

    Visit the official website

    Visit Website (opens in a new tab)

    Comments

    Sign in to join the discussion.

    No comments yet — be the first to share your thoughts.